E. Tupala et al., Effects of repeated low dose administration and withdrawal of haloperidol on sexual behaviour of male rats, PHARM TOX, 84(6), 1999, pp. 292-295
Neuroleptics are known to cause anhedonia and attenuate sexual behaviour at
therapeutic doses in humans. These effects are assumed to result from the
dopamine antagonism of the drugs. It has been observed that a mixed dopamin
e D-1/D-2 antagonist, haloperidol, may cause a reduction in the number of i
ntromissions required to achieve ejaculation. On the other hand, dopamine a
ntagonists are considered unable to modify sexual behaviour once the copula
tory sequence is initiated. In this study, male rats received low doses of
haloperidol (30 or 60 mu g/kg) before the investigation of sexual behaviour
in five consecutive days and the mating test was repeated after withdrawal
periods of four and five days. Haloperidol dose-dependently reduced introm
ission frequency, and this effect was maintained for four days after withdr
awal. Ejaculation latency was reduced in all groups, including controls. Th
e results indicate that at low doses haloperidol dose-dependently reduces i
ntromission frequency, and the effect of a repeated dosage may persist seve
ral days after cessation of medication.